At Hill-Rom / Welch Allyn cybersecurity is a very serious issue and we maintain continued vigilance of cybersecurity threats and protection. We strive to integrate cybersecurity protection as up to date as possible in our products. Each release of a new software version includes a risk assessment review of cybersecurity and most often include updated additional security protection features within them.
In addition to incorporating cybersecurity controls into the design and development of our medical devices, Welch Allyn regularly monitors vulnerabilities and conducts risk and impact assessments accordingly. We review the list of vulnerabilities reported and make every effort to ensure that those vulnerabilities are mitigated. Our responsible disclosure policy is available below.
Any deployment of networked products leverages a customer’s existing IT infrastructure. Welch Allyn’s network best practices guide, which sets forth required and recommended network settings and configurations to enable proper connectivity, advises customers to conduct a hazards analysis pursuant to IEC 80001 (Application of Risk Management for IT-networks Incorporating Medical Devices) prior to deployment in order to identify and remedy any interoperability issues.
At Hill-Rom, we consider the security of our systems a top priority.
If you discover a vulnerability, we would like to know about it so we can take steps to address it as quickly as possible. We would like to ask you to help us better protect our clients and our systems.
Please do the following:
Please do NOT:
What we promise:
We strive to resolve all problems as quickly as possible, and we appreciate your assistance in bringing a vulnerability to our attention.
Publication Date: November 15, 2019
Last Revised Date: October 30, 2019
In accordance with FDA and US Homeland regulations, Hill-Rom has evaluated the impact of Urgent 11 vulnerabilities on its products. Click here to get the notification.